New blood markers could predict brain bleed complications

NCT ID NCT07665255

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will measure certain proteins in the blood of people who have had a brain hemorrhage (bleeding in the brain) and compare them to healthy volunteers. The goal is to see if these proteins are linked to inflammation after the bleed. No drugs or treatments are being tested—just blood samples and medical scans. The study involves 60 participants and is not yet recruiting.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could help identify blood markers that predict inflammation after a brain bleed, potentially guiding future treatments.
What could go wrong
This is a small, early observational study with no treatment. It only looks at blood markers, so it may not lead to any direct patient benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INTRACEREBRAL HEMORRHAGE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

intracerebral hemorrhage Neuroinflammatory Diseases

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

More trials for these conditions

Other studies related to the condition(s) this trial covers.